Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

8
Number of overlapping holdings
7.3%
% of IXJ's 114 holdings also in IHE
23.5%
% of IHE's 34 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IXJ |
Weight in IHE |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 7.0% | 26.1% | 7.0% | |
JOHNSON & JOHNSON | 5.4% | 23.4% | 5.4% | |
MERCK & CO. INC. | 3.8% | 4.7% | 3.8% | |
PFIZER INC | 2.5% | 4.3% | 2.5% | |
BRISTOL-MYERS SQUIBB CO | 1.5% | 4.1% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to IHE
UNITEDHEALTH GROUP INC | 7.4% | |
ABBVIE INC | 3.6% | |
NOVARTIS AG | 3.0% | |
ASTRAZENECA PLC | 2.9% | |
THERMO FISHER SCIENTIFIC INC | 2.8% | |
ROCHE HOLDING LTD | 2.8% | |
ABBOTT LABORATORIES | 2.6% | |
DANAHER CORP | 2.1% | |
AMGEN INC | 2.1% | |
ANTHEM INC | 1.7% |
IXJ Underweight Relative to IHE
ELI LILLY & CO | -19.1% | |
JOHNSON & JOHNSON | -18.1% | |
ROYALTY PHARMA PLC CLASS A | -4.6% | |
VIATRIS, INC. | -4.4% | |
ZOETIS INC | -3.5% | |
JAZZ PHARMACEUTICALS PLC | -3.4% | |
CATALENT INC | -3.0% | |
ELANCO ANIMAL HEALTH, INC. | -2.6% | |
BRISTOL-MYERS SQUIBB CO | -2.5% | |
INTRA-CELLULAR THERAPIES INC | -2.3% |